USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/8344
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPantea, V.
dc.contributor.authorCebotarescu, V.
dc.contributor.authorSmesnoi, V.
dc.date.accessioned2020-03-30T22:15:03Z
dc.date.available2020-03-30T22:15:03Z
dc.date.issued2010
dc.identifier.citationPANTEA, V., CEBOTARESCU, V., SMESNOI, V. TThe treatment with cytomix of patients with chronic viral hepatitis B, C and mixed B and C. In: Curierul Medical. 2010, nr. 6(318), pp. 58-61. ISSN 1875-0666.en_US
dc.identifier.issn1875-0666
dc.identifier.urihttp://moldmedjournal.md/wp-content/uploads/2016/09/28.pdf
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/8344
dc.descriptionDepartment of Contagious Diseases, Postgraduate Study Faculty, Nicolae Testemitanu State Medical and Pharmaceutical University, Clinical Hospital of Contagious Diseases “Toma Ciorba,” Chisinau, Republic of Moldovaen_US
dc.description.abstractThe treatment with cytomix of 20 patients with chronic viral hepatitis B, C, and mixed B+C, for the duration of three months was favored. The improvement of clinical symptoms in patients with HVBC, HVC, and HVBC+HVCC. The decrease and normalization of liver and spleen sizes, and moderate decrease of cytolysis indices values (ALAT, ASAT). Seroconversion in the AgHBs and anti-Hbs system with the formation of anti-HBs (protective antibodies) in one of nine patients with the diagnosis HVBC. The improvement of immune status indices, which was more marked in patients with HVBC and HVBC+HVCC; there were no noted clinical, biochemical or immunological improvements in the patients of the control group.en_US
dc.description.abstractЛечение цитомиксом проводилось у 20 больных вирусными гепатитами В и С и микст гепатитами В+С в течении 3-х месяцев. Лечение привело к исчезновению клинической симптоматики, нормализации размеров печени и селезенки и снижению активности АЛАТ и АСАТ. Произошла сероконверсия в системе НBsAg и анти-HBs с образованием анти-HBs у одного больного из 9 с хроническим вирусным гепатитом В. Улучшение иммунологического статуса было более выражено у больных с хроническим вирусным гепатитом В и микст гепатитом В+С, чего не наблюдалось у пациентов контрольной группы.
dc.language.isoenen_US
dc.publisherMinisterul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu”en_US
dc.relation.ispartofCurierul Medical
dc.subjectchronicen_US
dc.subjectviralen_US
dc.subjecthepatitis Ben_US
dc.subjectCen_US
dc.subjectCytomixen_US
dc.subject.meshHepatitis B, Chronic--drug therapyen_US
dc.subject.meshHepatitis С, Chronic--drug therapyen_US
dc.subject.meshCitomix--therapeutic useen_US
dc.titleThe treatment with cytomix of patients with chronic viral hepatitis B, C and mixed B and Cen_US
dc.title.alternativeЛечение цитомиксом больных хроническим вирусным гепатитом В и С и микст гепатитом В+Сen_US
dc.typeArticleen_US
Appears in Collections:Curierul Medical, 2010, Vol. 318, Nr. 6

Files in This Item:
File Description SizeFormat 
The_Treatment_with_Cytomix_of_Patients_with_Chronic_Viral.pdf166.39 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback